Cargando…
Secretagogin, a marker for neuroendocrine cells, is more sensitive and specific in large cell neuroendocrine carcinoma compared with the markers CD56, CgA, Syn and Napsin A
A common method to distinguish large cell neuroendocrine carcinoma (LCNEC) from non-neuroendocrine large cell carcinoma (non-NE LCC) is from using specific immunohistochemistry markers, such as CgA, Syn, CD56 and Napsin A, however, the results remain controversial using these markers. Secretagogin (...
Autores principales: | Dong, Yunlong, Li, Yongwen, Liu, Renwang, Li, Ying, Zhang, Hongbing, Liu, Hongyu, Chen, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039081/ https://www.ncbi.nlm.nih.gov/pubmed/32194720 http://dx.doi.org/10.3892/ol.2020.11336 |
Ejemplares similares
-
Small-cell carcinoma of the prostate with negative CD56, NSE, Syn, and CgA indicators: A case report
por: Shi, Hong-Jin, et al.
Publicado: (2022) -
Clinical Routine Application of the Second-generation Neuroendocrine Markers ISL1, INSM1, and Secretagogin in Neuroendocrine Neoplasia: Staining Outcomes and Potential Clues for Determining Tumor Origin
por: Juhlin, Carl Christofer, et al.
Publicado: (2020) -
Napsin A as a marker of clear cell ovarian carcinoma
por: Skirnisdottir, Ingiridur, et al.
Publicado: (2013) -
Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: Napsin A expression and genomic alterations
por: Rekhtman, Natasha, et al.
Publicado: (2017) -
CEA Level, Radical Surgery, CD56 and CgA Expression Are Prognostic Factors for Patients With Locoregional Gastrin-Independent GNET
por: Li, Yuan, et al.
Publicado: (2016)